Our study examined whether repeated preventive oral administration of live probiotic bacterial strains Escherichia coli O83:K24:H31 (Ec O83), Escherichia coli Nissle 1917 O6:K5:H1 (Ec Nis) and Lactobacillus casei DN 114001 (Lc) can protect mice against dextran sodium sulfate (DSS)-induced colitis. A significant decrease in average symptom score was observed in Ec O83-, Ec Nis- and Lc-pretreated group (p < 0.05). Significant differences in body mass loss between Lc pretreated mice with DSS-induced colitis were found when compared with nontreated mice (p < 0.05). PBS pretreated mice had a significantly shorter colon than Ec O83-, Ec Nis- and Lc-pretreated mice (p < 0.05). Administration of Lc significantly decreased the severity of DSS induced histological marks of inflammation (p < 0.05). A significant difference (p < 0.05) was also found in specific IgA level against given probiotic in enteral fluid between colitic mice and healthy mice pretreated with Ec 083 and Ec Nis.

Clinic of Pediatric Surgery University Children Hospital Motol 150 06 Prague Czechia

See more in PubMed

Infect Immun. 2002 Apr;70(4):2057-64 PubMed

Gastroenterology. 2001 Feb;120(3):622-35 PubMed

Folia Microbiol (Praha). 2005;50(5):443-7 PubMed

Clin Exp Immunol. 1995 Dec;102(3):448-55 PubMed

Gastroenterology. 2001 Sep;121(3):580-91 PubMed

Gastroenterology. 1994 Dec;107(6):1643-52 PubMed

Infect Immun. 2001 Apr;69(4):2277-85 PubMed

Folia Microbiol (Praha). 1998;43(5):545-50 PubMed

Dig Dis. 2003;21(2):105-28 PubMed

Clin Microbiol Rev. 2003 Oct;16(4):658-72 PubMed

J Immunol. 2003 Nov 15;171(10):5507-13 PubMed

Clin Exp Immunol. 2000 Apr;120(1):46-50 PubMed

Cell. 1993 Oct 22;75(2):203-5 PubMed

Gastroenterology. 1999 May;116(5):1107-14 PubMed

Pediatr Res. 1991 Apr;29(4 Pt 1):396-9 PubMed

Gut. 2004 Jun;53(6):821-8 PubMed

Lancet. 1999 Aug 21;354(9179):635-9 PubMed

Appl Environ Microbiol. 2000 Jun;66(6):2578-88 PubMed

Folia Microbiol (Praha). 2003;48(2):281-7 PubMed

Immunol Lett. 2004 May 15;93(2-3):97-108 PubMed

Clin Exp Immunol. 2000 Jan;119(1):57-63 PubMed

Lab Invest. 1993 Aug;69(2):238-49 PubMed

Immunity. 1995 Aug;3(2):171-4 PubMed

Folia Microbiol (Praha). 2001;46(6):573-6 PubMed

Scand J Immunol. 2002 Feb;55(2):204-9 PubMed

Folia Microbiol (Praha). 2004;49(2):203-7 PubMed

Am J Gastroenterol. 2002 May;97(5):1182-6 PubMed

Immunol Rev. 2001 Aug;182:190-200 PubMed

Folia Microbiol (Praha). 2004;49(2):143-6 PubMed

J Dairy Res. 2003 May;70(2):165-73 PubMed

Folia Microbiol (Praha). 2001;46(6):565-72 PubMed

Am J Physiol. 1999 Apr;276(4 Pt 1):G941-50 PubMed

The Impact of Escherichia coli Probiotic Strain O83:K24:H31 on the Maturation of Dendritic Cells and Immunoregulatory Functions In Vitro and In Vivo

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917

Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment

Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition

Probiotic Lactobacillus strains: in vitro and in vivo studies

Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant)

Factors for bile tolerance in Lactococcus lactis: analysis by using plasmid variants

The protective potency of probiotic bacteria and their microbial products against enteric infections-review

Probiotic potential of enterococci isolated from canine feed

Effect of oral application of a probiotic E. coli strain on the intestinal microflora of children of allergic mothers during the first year of life

Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice